AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 193 filers reported holding AUDENTES THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 5.36 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $8,329,000 | +858.5% | 139,193 | +524.8% | 0.05% | +733.3% |
| Q1 2019 | $869,000 | -70.9% | 22,277 | -84.1% | 0.01% | -71.4% |
| Q4 2018 | $2,982,000 | +11.5% | 139,856 | +107.1% | 0.02% | +75.0% |
| Q3 2018 | $2,674,000 | +90.2% | 67,544 | +83.6% | 0.01% | +100.0% |
| Q2 2018 | $1,406,000 | -89.9% | 36,784 | -92.0% | 0.01% | -89.7% |
| Q1 2018 | $13,887,000 | +1125.7% | 462,116 | +1174.8% | 0.06% | +1350.0% |
| Q4 2017 | $1,133,000 | – | 36,250 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 294,013 | $11,131,000 | 9.27% |
| GREAT POINT PARTNERS LLC | 1,922,937 | $72,802,000,000 | 8.08% |
| Versant Venture Management, LLC | 553,916 | $20,971,260,000 | 6.11% |
| Foresite Capital Management III, LLC | 315,331 | $11,938,000 | 3.92% |
| Casdin Capital, LLC | 965,000 | $36,534,900,000 | 3.42% |
| Sofinnova Investments, Inc. | 933,640 | $35,348,000 | 3.25% |
| Opaleye Management Inc. | 280,000 | $10,601,000 | 3.23% |
| Redmile Group, LLC | 2,972,167 | $112,526,000 | 3.18% |
| PFM Health Sciences, LP | 3,228,679 | $122,238,000 | 2.32% |
| Eversept Partners, LP | 159,526 | $6,039,654 | 1.69% |